|
WO2002085923A2
(en)
*
|
2001-04-19 |
2002-10-31 |
The Scripps Research Institute |
In vivo incorporation of unnatural amino acids
|
|
WO2003033521A1
(en)
|
2001-10-16 |
2003-04-24 |
Massachusetts Institute Of Technology |
Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
|
|
US20030148391A1
(en)
*
|
2002-01-24 |
2003-08-07 |
Salafsky Joshua S. |
Method using a nonlinear optical technique for detection of interactions involving a conformational change
|
|
US7112435B1
(en)
|
2002-08-07 |
2006-09-26 |
Ambit Biosciences Corporation |
Uncoupling of DNA insert propagation and expression of protein for phage display
|
|
US20040038273A1
(en)
*
|
2002-06-17 |
2004-02-26 |
Whitehead Institute For Biomedical Research |
Bifunctional tRNA for in vitro selection
|
|
AU2003252153A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Mds Proteomics Inc. |
Improved systems and methods for analysis of protein post-translational modification
|
|
US7897381B2
(en)
*
|
2002-08-07 |
2011-03-01 |
Ambit Biosciences Corporation |
Uncoupling of DNA insert propagation and expression of protein for phage display
|
|
US7833741B2
(en)
*
|
2002-08-07 |
2010-11-16 |
Ambit Biosciences Corporation |
Uncoupling of DNA insert propagation and expression of protein for phage display
|
|
US7563600B2
(en)
|
2002-09-12 |
2009-07-21 |
Combimatrix Corporation |
Microarray synthesis and assembly of gene-length polynucleotides
|
|
JP4444113B2
(ja)
|
2002-10-16 |
2010-03-31 |
ザ スクリップス リサーチ インスティテュート |
ケトアミノ酸の部位特異的蛋白質組込み方法
|
|
MXPA05003978A
(es)
|
2002-10-16 |
2005-06-22 |
Scripps Research Inst |
Sintesis de glicoproteinas.
|
|
CA2508939A1
(en)
|
2002-12-22 |
2004-07-15 |
The Scripps Research Institute |
Protein arrays
|
|
WO2004060403A2
(en)
|
2003-01-06 |
2004-07-22 |
Angiochem Inc. |
Aprotinin and anglos as carriers across the blood-brain barrier
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
JP2006180701A
(ja)
*
|
2003-02-10 |
2006-07-13 |
Institute Of Physical & Chemical Research |
チロシルｔＲＮＡ合成酵素の変異体及びその作製方法
|
|
AU2013201487B2
(en)
*
|
2003-04-17 |
2014-09-18 |
The Scripps Research Institute |
Expanding the eukaryotic genetic code
|
|
JP5642916B2
(ja)
|
2003-04-17 |
2014-12-17 |
ザ スクリプス リサーチ インスティテュート |
真核遺伝コードの拡張
|
|
WO2004110964A2
(en)
*
|
2003-06-16 |
2004-12-23 |
Nuevolution A/S |
Encoded molecules by translation (emt)
|
|
EP2410331B1
(en)
|
2003-06-18 |
2015-09-23 |
The Scripps Research Institute |
Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids
|
|
US20060160175A1
(en)
*
|
2003-07-07 |
2006-07-20 |
The Scripps Research Institute |
Compositions of orthogonal leucyl-trna and aminoacyl-trna synthetase pairs and uses thereof
|
|
EP1649004A4
(en)
*
|
2003-07-07 |
2008-04-09 |
Scripps Research Inst |
COMPOSITIONS WITH PAIRS OF ORTHOGONAL LYSYL-TRNA AND AMINOACYL-TRNA-SYNTHETASE AND USES THEREOF
|
|
WO2005007624A2
(en)
*
|
2003-07-07 |
2005-01-27 |
The Scripps Research Institute |
Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
|
|
EP1668114B1
(en)
*
|
2003-08-18 |
2009-11-04 |
The Regents of the University of California |
Polypeptide display libraries and methods of making and using thereof
|
|
PT1687401E
(pt)
|
2003-10-14 |
2013-02-26 |
Scripps Research Inst |
Incorporação de aminoácidos activos em oxidação-redução específica do local em proteínas
|
|
AU2004314710A1
(en)
*
|
2003-12-12 |
2005-08-11 |
Conjugon, Inc. |
Systems for tightly regulated gene expression
|
|
US7741071B2
(en)
*
|
2003-12-18 |
2010-06-22 |
The Scripps Research Institute |
Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
|
|
BRPI0507169A
(pt)
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
|
|
AU2005222788A1
(en)
*
|
2004-02-27 |
2005-09-29 |
President And Fellows Of Harvard College |
Polynucleotide synthesis
|
|
FR2868081A1
(fr)
*
|
2004-03-23 |
2005-09-30 |
Libragen Sa |
Methode d'identification de famille de voie metabolique par selection positive
|
|
US20050260711A1
(en)
*
|
2004-03-30 |
2005-11-24 |
Deepshikha Datta |
Modulating pH-sensitive binding using non-natural amino acids
|
|
EP1757686A4
(en)
*
|
2004-04-09 |
2008-03-12 |
Chugai Pharmaceutical Co Ltd |
Cell death inducer
|
|
US20050287639A1
(en)
|
2004-05-17 |
2005-12-29 |
California Institute Of Technology |
Methods of incorporating amino acid analogs into proteins
|
|
JP2008500050A
(ja)
*
|
2004-05-25 |
2008-01-10 |
ザ スクリップス リサーチ インスティテュート |
結晶構造決定のための重原子含有非天然アミノ酸の部位特異的蛋白質組込み
|
|
US20060008844A1
(en)
*
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
|
US7632924B2
(en)
*
|
2004-06-18 |
2009-12-15 |
Ambrx, Inc. |
Antigen-binding polypeptides and their uses
|
|
ZA200609926B
(en)
*
|
2004-06-18 |
2009-02-25 |
Ambrx Inc |
Novel antigen-binding polypeptides and their uses
|
|
SI1771474T1
(sl)
|
2004-07-20 |
2010-06-30 |
Genentech Inc |
Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
|
|
WO2006091231A2
(en)
*
|
2004-07-21 |
2006-08-31 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
|
AU2005286722B2
(en)
*
|
2004-09-21 |
2010-12-02 |
The Scripps Research Institute |
In vivo incorporation of alkynyl amino acids into proteins in eubacteria
|
|
US20080171317A1
(en)
*
|
2004-09-22 |
2008-07-17 |
The Scripps Research Institute |
Site-Specific Labeling of Proteins for Nmr Studies
|
|
JP2008523786A
(ja)
*
|
2004-10-18 |
2008-07-10 |
コドン デバイシズ インコーポレイテッド |
高忠実度合成ポリヌクレオチドのアセンブリ方法
|
|
US20070122817A1
(en)
*
|
2005-02-28 |
2007-05-31 |
George Church |
Methods for assembly of high fidelity synthetic polynucleotides
|
|
JP2008516637A
(ja)
*
|
2004-10-20 |
2008-05-22 |
ザ スクリップス リサーチ インスティテュート |
真正細菌へのｎ−アセチルガラクトサミンアミノ酸のインビボ部位特異的組込み
|
|
CN101048506B
(zh)
|
2004-10-27 |
2013-06-26 |
斯克利普斯研究院 |
体内掺入非天然氨基酸的正交翻译组分
|
|
AU2011204773B2
(en)
*
|
2004-10-27 |
2012-02-02 |
The Scripps Research Institute |
Orthogonal translation components for the in vivo incorporation of unnatural amino acids
|
|
WO2006050247A2
(en)
|
2004-10-29 |
2006-05-11 |
Neose Technologies, Inc. |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
WO2006055898A2
(en)
*
|
2004-11-20 |
2006-05-26 |
Massachusetts Institute Of Technology |
Orthogonal suppressor trnas and aminoacyl-trna synthetases and uses thereof
|
|
US20090023139A1
(en)
*
|
2004-11-22 |
2009-01-22 |
Kazuya Nishikawa |
Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna
|
|
AU2013205030B2
(en)
*
|
2004-12-22 |
2016-05-12 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
CN103520735B
(zh)
*
|
2004-12-22 |
2015-11-25 |
Ambrx公司 |
包含非天然编码的氨基酸的人生长激素配方
|
|
EP1836298B1
(en)
|
2004-12-22 |
2012-01-18 |
Ambrx, Inc. |
COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
|
|
BRPI0519430A2
(pt)
*
|
2004-12-22 |
2009-02-10 |
Ambrx Inc |
hormânio do crescimento humano modificado
|
|
EP2399893B1
(en)
|
2004-12-22 |
2018-08-15 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
EP1836316A4
(en)
*
|
2004-12-22 |
2009-07-22 |
Ambrx Inc |
PROCESS FOR EXPRESSION AND CLEANING OF RECOMBINANT HUMAN GROWTH HORMONE
|
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
|
WO2006107813A2
(en)
*
|
2005-04-05 |
2006-10-12 |
Yale University |
Site specific incorporation of phosphoserine into polypeptides using phosphoseryl-trna synthetase
|
|
WO2006121569A2
(en)
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
WO2006122224A1
(en)
*
|
2005-05-11 |
2006-11-16 |
Wayne State University |
Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
|
|
EP1891092A4
(en)
*
|
2005-06-03 |
2011-12-21 |
Ambrx Inc |
INSTALLATION OF NATURALLY CODED AMINO ACIDS IN PROTEINS
|
|
AU2006255122B2
(en)
*
|
2005-06-03 |
2010-10-21 |
Ambrx, Inc. |
Improved human interferon molecules and their uses
|
|
KR101367544B1
(ko)
*
|
2005-06-10 |
2014-02-26 |
추가이 세이야쿠 가부시키가이샤 |
메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
|
|
WO2007005053A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Codon Devices, Inc. |
Hierarchical assembly methods for genome engineering
|
|
ES2744225T3
(es)
|
2005-07-15 |
2020-02-24 |
Angiochem Inc |
Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
|
|
JP5213706B2
(ja)
*
|
2005-07-15 |
2013-06-19 |
メディカル リサーチ カウンシル |
直交性リボソームｍＲＮＡペアに関する組成物および方法
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
AU2005335491B2
(en)
|
2005-08-18 |
2010-11-25 |
Ambrx, Inc. |
Compositions of tRNA and uses thereof
|
|
AU2006284651C1
(en)
|
2005-08-31 |
2013-09-12 |
The Regents Of The University Of California |
Cellular libraries of peptide sequences (CLiPS) and methods of using the same
|
|
BRPI0617191A2
(pt)
*
|
2005-10-12 |
2011-07-19 |
Scripps Research Inst |
modificação pós-traducional de polipeptìdeos expressos em fagos
|
|
DK2339014T3
(en)
|
2005-11-16 |
2015-07-20 |
Ambrx Inc |
Methods and compositions comprising non-natural amino acids
|
|
WO2007070659A2
(en)
*
|
2005-12-14 |
2007-06-21 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
CA2633524A1
(en)
|
2005-12-22 |
2007-07-05 |
Pacific Biosciences Of California, Inc. |
Polymerases for nucleotide analogue incorporation
|
|
CN105085313A
(zh)
*
|
2005-12-30 |
2015-11-25 |
Ambrx公司 |
含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
|
|
AU2007215566A1
(en)
*
|
2006-01-19 |
2007-08-23 |
Ambrx, Inc. |
Non-natural amino acid polypeptides having modulated immunogenicity
|
|
US20070178554A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Nima Shiva |
Orthogonal Aminoacyl Synthetase-tRNA Pairs for Incorporating Unnatural Amino Acids Into Proteins
|
|
WO2007090198A2
(en)
*
|
2006-02-01 |
2007-08-09 |
Encode Bio, Inc. |
Fluorescent assays using orthogonal trna - aminoacyl synthetase pairs
|
|
WO2007092475A2
(en)
*
|
2006-02-06 |
2007-08-16 |
Franklin And Marshall College |
Site-specific incorporation of fluorinated amino acids into proteins
|
|
AU2007224019A1
(en)
|
2006-03-03 |
2007-09-13 |
California Institute Of Technology |
Site-specific incorporation of amino acids into molecules
|
|
KR20080106430A
(ko)
*
|
2006-03-09 |
2008-12-05 |
더 스크립스 리서치 인스티튜트 |
진정 세균 숙주 세포 내에서의 직교형 번역 성분의 발현을 위한 시스템
|
|
WO2007109035A2
(en)
|
2006-03-16 |
2007-09-27 |
The Scripps Research Institute |
Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
|
|
US20080096819A1
(en)
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
JP5313129B2
(ja)
|
2006-05-02 |
2013-10-09 |
アロザイン， インコーポレイテッド |
非天然アミノ酸置換ポリペプチド
|
|
AU2007267950B2
(en)
|
2006-05-23 |
2012-08-16 |
The Scripps Research Institute |
Genetically encoded fluorescent coumarin amino acids
|
|
KR101459789B1
(ko)
*
|
2006-06-09 |
2014-11-07 |
노파르티스 아게 |
안정화된 인슐린-유사 성장 인자 폴리펩티드
|
|
WO2008001947A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Riken |
MUTANT SepRS, AND METHOD FOR SITE-SPECIFIC INTRODUCTION OF PHOSPHOSERINE INTO PROTEIN BY USING THE SAME
|
|
WO2008066583A2
(en)
*
|
2006-06-29 |
2008-06-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-free synthesis of proteins containing unnatural amino acids
|
|
US20100150927A1
(en)
*
|
2006-07-13 |
2010-06-17 |
Chugai Seiyaku Kabushiki Kaisha |
Cell death inducer
|
|
AU2013202770B2
(en)
*
|
2006-09-08 |
2015-08-20 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
|
EP2064333B1
(en)
|
2006-09-08 |
2014-02-26 |
Ambrx, Inc. |
Suppressor trna transcription in vertebrate cells
|
|
JP5399906B2
(ja)
|
2006-09-08 |
2014-01-29 |
アンブルックス，インコーポレイテッド |
脊椎動物細胞用のハイブリッドサプレッサーｔｒｎａ
|
|
JP2010502221A
(ja)
*
|
2006-09-08 |
2010-01-28 |
アンブルックス，インコーポレイテッド |
脊椎動物細胞による非天然アミノ酸の部位特異的組み込み
|
|
AU2012203737B2
(en)
*
|
2006-09-08 |
2014-06-19 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
|
JP5385143B2
(ja)
*
|
2006-09-21 |
2014-01-08 |
ザ スクリプス リサーチ インスティチュート |
真正細菌における選択的に硫酸化された蛋白質の遺伝的にプログラムされた発現
|
|
WO2008073184A2
(en)
|
2006-10-18 |
2008-06-19 |
The Scripps Research Institute |
Genetic incorporation of unnatural amino acids into proteins in mammalian cells
|
|
WO2008065372A2
(en)
|
2006-11-28 |
2008-06-05 |
Nautilus Biotech, S.A. |
Modified erythropoietin polypeptides and uses thereof for treatment
|
|
EP1936340A1
(en)
*
|
2006-12-21 |
2008-06-25 |
Koninklijke Philips Electronics N.V. |
Sub wavelength aperture
|
|
EP2112928A4
(en)
*
|
2007-02-22 |
2014-01-08 |
Univ Utah Res Found |
SYNTHESIS OF NOVEL XYLOSIDES AND ITS POSSIBLE USES
|
|
CL2008000719A1
(es)
*
|
2007-03-12 |
2008-09-05 |
Univ Tokushima Chugai Seiyaku |
Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
|
|
CN107501407B
(zh)
|
2007-03-30 |
2022-03-18 |
Ambrx公司 |
经修饰fgf-21多肽和其用途
|
|
US8183037B2
(en)
*
|
2007-04-13 |
2012-05-22 |
The Salk Institute For Biological Studies |
Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal tRNA/synthetase pairs
|
|
US8114630B2
(en)
*
|
2007-05-02 |
2012-02-14 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
WO2009036460A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Ambrx, Inc. |
Modified human apolipoprotein a-i polypeptides and their uses
|
|
CA2702061A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Synthetic Genomics, Inc. |
System and method for producing synthetic microorganisms capable of translating proteins containing non-standard amino acids
|
|
US8673591B2
(en)
|
2007-10-25 |
2014-03-18 |
The Scripps Research Institute |
Genetic incorporation of 3-aminotyrosine into reductases
|
|
JP5513398B2
(ja)
*
|
2007-11-02 |
2014-06-04 |
ザ スクリプス リサーチ インスティチュート |
非天然アミノ酸を含有する蛋白質を使用する指向的進化
|
|
BRPI0820327A2
(pt)
|
2007-11-02 |
2020-10-06 |
Novartis Ag |
moléculas e métodos para modulação de proteína relacionada ao receptor de lipoproteína de baixa densidade 6 (lrp6)
|
|
WO2009059056A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Scripps Research Institute |
A genetically encoded boronate amino acid
|
|
WO2009064416A2
(en)
*
|
2007-11-15 |
2009-05-22 |
The Scripps Research Institute |
Genetic incorporation of an alpha-hydroxy acid into proteins to generate ester backbone linkages at defined sites
|
|
MX2010005317A
(es)
*
|
2007-11-20 |
2010-06-02 |
Ambrx Inc |
Polipeptidos de insulina modificados y sus usos.
|
|
CN101939410A
(zh)
*
|
2007-12-11 |
2011-01-05 |
斯克利普斯研究院 |
甲基营养酵母菌巴斯德毕赤酵母中的体内非天然氨基酸表达
|
|
CN104651381A
(zh)
|
2008-01-03 |
2015-05-27 |
巴斯夫酶有限责任公司 |
转移酶和氧化还原酶、编码它们的核酸以及其制备和应用方法
|
|
EP2249853A4
(en)
|
2008-01-30 |
2012-12-26 |
Univ Indiana Res & Tech Corp |
ESTER BASED PEPTIDE PRODRUGS
|
|
MX344166B
(es)
|
2008-02-08 |
2016-12-07 |
Ambrx Inc |
Leptina-polipeptidos modificados y sus usos.
|
|
EP2249865A4
(en)
*
|
2008-02-08 |
2012-04-04 |
Scripps Research Inst |
BREAKING IMMUNOLOGICAL TOLERANCE WITH A GENETICALLY ENCODED UNNATURAL AMINO ACID
|
|
US20110015345A1
(en)
*
|
2008-03-19 |
2011-01-20 |
Ambrx, Inc. |
Modified FGF-23 Polypeptides and Their Uses
|
|
WO2009117726A2
(en)
*
|
2008-03-21 |
2009-09-24 |
The Regents Of The University Of California |
High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluoresent proteins
|
|
EP2604279A1
(en)
|
2008-03-27 |
2013-06-19 |
ZymoGenetics, Inc. |
Compositions and methods for inhibiting PDGFRBETA and VEGF-A
|
|
EP2942404B1
(en)
|
2008-03-31 |
2016-11-23 |
Pacific Biosciences of California, Inc. |
Generation of modified polymerases for improved accuracy in single molecule sequencing
|
|
EA201001734A1
(ru)
|
2008-05-02 |
2011-10-31 |
Новартис Аг |
Улучшенные связывающие молекулы на основе фибронектина и их применение
|
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
WO2009155513A2
(en)
|
2008-06-20 |
2009-12-23 |
Novartis Ag |
Immunoglobulins with reduced aggregation
|
|
CN102159708B
(zh)
|
2008-06-26 |
2016-08-31 |
Atyr医药公司 |
包含具有非常规生物活性的甘氨酰-tRNA合成酶的组合物和方法
|
|
AU2009270405B2
(en)
*
|
2008-06-30 |
2014-06-05 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Functionalized polypeptides
|
|
EP2769711A1
(en)
*
|
2008-07-10 |
2014-08-27 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Methods and Compositions for Enhanced Delivery of Macromolecules
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
CN102159230A
(zh)
|
2008-07-23 |
2011-08-17 |
Ambrx公司 |
经修饰的牛g-csf多肽和其用途
|
|
US9182406B2
(en)
*
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
|
US20110195900A1
(en)
*
|
2008-08-19 |
2011-08-11 |
Ferring B.V. |
Peptidic pth receptor agonists
|
|
BR122012024318A2
(pt)
|
2008-09-26 |
2019-07-30 |
Ambrx, Inc. |
Polipeptídeos modificados de eritropoetina animal e seus usos
|
|
AU2009296267B2
(en)
|
2008-09-26 |
2013-10-31 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
|
CA2740316A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
WO2010048582A1
(en)
|
2008-10-24 |
2010-04-29 |
Irm Llc |
Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
|
|
CA2745524C
(en)
|
2008-12-05 |
2020-06-09 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
US8609383B2
(en)
|
2008-12-10 |
2013-12-17 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
|
US20090197339A1
(en)
*
|
2008-12-10 |
2009-08-06 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
|
|
US8853353B2
(en)
|
2008-12-17 |
2014-10-07 |
Angiochem, Inc. |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
|
JP5789515B2
(ja)
*
|
2008-12-19 |
2015-10-07 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ |
インスリン類似体
|
|
PE20120332A1
(es)
|
2008-12-19 |
2012-04-14 |
Univ Indiana Res & Tech Corp |
Profarmacos de peptido de la superfamilia de glucagon basado en amida
|
|
AU2009335715B2
(en)
|
2008-12-19 |
2016-09-15 |
Indiana University Research And Technology Corporation |
Amide-based insulin prodrugs
|
|
WO2010080605A1
(en)
*
|
2008-12-19 |
2010-07-15 |
Indiana University Research And Technology Corporation |
Dipeptide linked medicinal agents
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
EP2403864B1
(en)
|
2009-02-27 |
2015-08-12 |
Atyr Pharma, Inc. |
Polypeptide structural motifs associated with cell signaling activity
|
|
US20100310576A1
(en)
*
|
2009-03-31 |
2010-12-09 |
Adams Ryan A |
COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
|
|
MX2011011023A
(es)
|
2009-04-20 |
2012-01-20 |
Angiochem Inc |
Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
|
|
AU2010247938B2
(en)
|
2009-05-11 |
2016-02-18 |
Pelican Technology Holdings, Inc. |
Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
|
|
MX2011012665A
(es)
|
2009-06-04 |
2012-03-07 |
Novartis Ag |
Metodos para identificacion de sitios para conjugacion de igg.
|
|
RU2012103240A
(ru)
|
2009-07-02 |
2013-08-10 |
Ангиокем Инк. |
Мультимерные пептидные конъюгаты и их применение
|
|
US20110054019A1
(en)
*
|
2009-09-01 |
2011-03-03 |
Pedro Anastacio Serrano-Ojeda |
Cancer Starvation Therapy
|
|
US10292956B2
(en)
|
2009-09-01 |
2019-05-21 |
Serbig Pharmaceutics Corp. |
Cancer starvation therapy
|
|
EP2311947A1
(en)
*
|
2009-10-14 |
2011-04-20 |
Ludwig-Maximilians-Universität München |
Protein synthesis via click chemistry
|
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
|
WO2011051327A2
(en)
|
2009-10-30 |
2011-05-05 |
Novartis Ag |
Small antibody-like single chain proteins
|
|
WO2011051466A1
(en)
|
2009-11-02 |
2011-05-05 |
Novartis Ag |
Anti-idiotypic fibronectin-based binding molecules and uses thereof
|
|
US20120282276A1
(en)
|
2009-11-05 |
2012-11-08 |
The Regents Of The University Of Michigan |
Biomarkers predictive of progression of fibrosis
|
|
US9051593B2
(en)
|
2009-12-21 |
2015-06-09 |
Trustees Of Dartmouth College |
Recombinant prokaryotes and use thereof for production of O-glycosylated proteins
|
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
|
BR112012015597A2
(pt)
|
2009-12-21 |
2017-01-31 |
Ambrx Inc |
peptídeos de somatotropina suínos modificados e seus usos
|
|
AU2011210840B2
(en)
|
2010-01-27 |
2014-12-11 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
|
WO2011092233A1
(en)
|
2010-01-29 |
2011-08-04 |
Novartis Ag |
Yeast mating to produce high-affinity combinations of fibronectin-based binders
|
|
US20120296403A1
(en)
|
2010-02-10 |
2012-11-22 |
Novartis Ag |
Methods and compounds for muscle growth
|
|
US8674064B2
(en)
*
|
2010-03-03 |
2014-03-18 |
Onkologix Ltd |
Immunogenic compositions against human progastrin peptides
|
|
US8464858B2
(en)
|
2010-03-12 |
2013-06-18 |
Cabin Creek Inc. |
Conveyor belt scraper and system for the same
|
|
WO2011119771A2
(en)
*
|
2010-03-23 |
2011-09-29 |
The Salk Institute For Biological Studies |
Methods and compositions for detecting protein modifications
|
|
CA2797093C
(en)
|
2010-04-26 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
|
EP2563381B1
(en)
|
2010-04-27 |
2017-08-09 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
AU2011248521B2
(en)
|
2010-04-27 |
2017-03-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases
|
|
CN103097524B
(zh)
|
2010-04-28 |
2016-08-03 |
Atyr医药公司 |
与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
|
EP2563383B1
(en)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
|
ES2668207T3
(es)
|
2010-05-03 |
2018-05-17 |
Atyr Pharma, Inc. |
Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de metionil-ARNt sintetasas
|
|
AU2011248227B2
(en)
|
2010-05-03 |
2016-12-01 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
|
CN103096925A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
EP2566516B1
(en)
|
2010-05-03 |
2019-07-03 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
|
|
JP6008844B2
(ja)
|
2010-05-04 |
2016-10-19 |
エータイアー ファーマ， インコーポレイテッド |
ｐ３８ＭＵＬＴＩ−ｔＲＮＡ合成酵素複合体のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
CN103096909A
(zh)
|
2010-05-04 |
2013-05-08 |
Atyr医药公司 |
与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
EP2568996B1
(en)
|
2010-05-14 |
2017-10-04 |
aTyr Pharma, Inc. |
Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
US9034598B2
(en)
|
2010-05-17 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
|
|
CN103096913B
(zh)
|
2010-05-27 |
2017-07-18 |
Atyr 医药公司 |
与谷氨酰胺酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2800281C
(en)
|
2010-06-01 |
2021-01-12 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
|
|
JP5969469B2
(ja)
|
2010-06-16 |
2016-08-17 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ |
インスリン受容体に対して高い活性を示す単鎖インスリンアゴニスト
|
|
WO2011158895A1
(ja)
*
|
2010-06-16 |
2011-12-22 |
独立行政法人理化学研究所 |
非天然タンパク質製造用の組換え細菌の作製方法、及びその利用
|
|
EP2588126A4
(en)
|
2010-06-24 |
2015-07-08 |
Univ Indiana Res & Tech Corp |
AMID-BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS
|
|
EP2585102B1
(en)
|
2010-06-24 |
2015-05-06 |
Indiana University Research and Technology Corporation |
Amide-based insulin prodrugs
|
|
KR20130102534A
(ko)
|
2010-07-12 |
2013-09-17 |
에이티와이알 파마, 인코포레이티드 |
히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
|
|
US8999321B2
(en)
|
2010-07-12 |
2015-04-07 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
|
KR20180059575A
(ko)
*
|
2010-07-12 |
2018-06-04 |
에이티와이알 파마, 인코포레이티드 |
아스파르틸trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
EA030886B1
(ru)
|
2010-08-17 |
2018-10-31 |
Амбркс, Инк. |
Модифицированные полипептиды релаксина, содержащие некодируемую в природе аминокислоту, связанную с полимером, и их применение
|
|
CN103108650A
(zh)
|
2010-08-25 |
2013-05-15 |
Atyr医药公司 |
与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
EP2640745B1
(en)
|
2010-09-10 |
2018-11-07 |
MedImmune Limited |
Bivalent and bispecific anti-il6/anti-il23 antibodies
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
|
CN103118696B
(zh)
*
|
2010-10-06 |
2020-02-14 |
Atyr 医药公司 |
与色氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物
|
|
US9090928B2
(en)
|
2010-10-07 |
2015-07-28 |
Yale University |
Site-specific incorporation of phosphoserine into proteins in Escherichia coli
|
|
US9023791B2
(en)
|
2010-11-19 |
2015-05-05 |
Novartis Ag |
Fibroblast growth factor 21 mutations
|
|
WO2012097333A2
(en)
|
2011-01-14 |
2012-07-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
|
|
ES2661095T3
(es)
|
2011-02-03 |
2018-03-27 |
European Molecular Biology Laboratory |
Aminoácidos no naturales que comprenden un grupo análogo de ciclooctinilo o trans-ciclooctenilo y usos de los mismos
|
|
GB2503604B
(en)
|
2011-03-21 |
2020-04-22 |
Biodesy Llc |
Classification of kinase inhibitors using second harmonic optical techniques
|
|
EP2694083A2
(en)
|
2011-04-01 |
2014-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders
|
|
DK2694095T3
(en)
|
2011-04-05 |
2018-05-28 |
Longevity Biotech Inc |
COMPOSITIONS COMPREHENSIVE GLUCAGON ANALOGS AND METHODS FOR PREPARING AND USING THE SAME
|
|
CN110078789A
(zh)
|
2011-05-27 |
2019-08-02 |
Ambrx 公司 |
含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
|
|
KR102356286B1
(ko)
|
2011-05-27 |
2022-02-08 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
US10876142B2
(en)
|
2011-07-11 |
2020-12-29 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
|
US11788111B2
(en)
|
2011-07-11 |
2023-10-17 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
|
WO2013009868A1
(en)
|
2011-07-11 |
2013-01-17 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
|
US10240158B2
(en)
|
2011-07-11 |
2019-03-26 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
|
CN102888387B
(zh)
*
|
2011-07-21 |
2015-03-18 |
中国科学院生物物理研究所 |
3-氯代酪氨酸翻译系统及其应用
|
|
US10323236B2
(en)
|
2011-07-22 |
2019-06-18 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
CN102925427B
(zh)
*
|
2011-08-08 |
2014-01-22 |
中国科学院生物物理研究所 |
丙烯酰赖氨酸翻译系统及其应用
|
|
US9714419B2
(en)
|
2011-08-09 |
2017-07-25 |
Atyr Pharma, Inc. |
PEGylated tyrosyl-tRNA synthetase polypeptides
|
|
UY34347A
(es)
|
2011-09-26 |
2013-04-30 |
Novartis Ag |
Proteínas de función dual para tratar trastornos metabólicos
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
WO2013086228A1
(en)
*
|
2011-12-06 |
2013-06-13 |
Atyr Pharma, Inc. |
Pegylated aspartyl-trna synthetase polypeptides
|
|
WO2013086216A1
(en)
|
2011-12-06 |
2013-06-13 |
Atyr Pharma, Inc. |
Improved aspartyl-trna synthetases
|
|
BR112014015156A2
(pt)
|
2011-12-20 |
2020-10-27 |
Indiana University Research And Technology Corporation |
análogos de insulina à base de ctp, seus métodos de produção e uso no tratamento de hiperglicemia, bem como sequência de ácido nucleico e célula hospedeira
|
|
TW202446781A
(zh)
|
2011-12-28 |
2024-12-01 |
日商中外製藥股份有限公司 |
胜肽化合物之製造方法
|
|
CA2858613A1
(en)
|
2011-12-29 |
2013-08-08 |
Atyr Pharma, Inc. |
Aspartyl-trna synthetase-fc conjugates
|
|
US9395358B2
(en)
|
2012-02-05 |
2016-07-19 |
Biodesy, Inc. |
Methods for detecting allosteric modulators of protein
|
|
EP2814514B1
(en)
|
2012-02-16 |
2017-09-13 |
Atyr Pharma, Inc. |
Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
|
|
SG11201406769RA
(en)
|
2012-05-10 |
2014-11-27 |
Massachusetts Inst Technology |
Agents for influenza neutralization
|
|
CN108727466B
(zh)
|
2012-06-07 |
2023-04-28 |
Ambrx公司 |
前列腺特异性膜抗原抗体药物结合物
|
|
EP2859017B1
(en)
|
2012-06-08 |
2019-02-20 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
KR102190832B1
(ko)
|
2012-06-19 |
2020-12-15 |
암브룩스, 인코포레이티드 |
항cd70 항체 약물 컨쥬게이트
|
|
WO2014004639A1
(en)
|
2012-06-26 |
2014-01-03 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
CN103571804B
(zh)
*
|
2012-08-10 |
2015-08-12 |
中国科学院生物物理研究所 |
3-吡唑基酪氨酸翻译系统及其应用
|
|
AU2013305744B2
(en)
|
2012-08-22 |
2017-06-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Engineered anthrax lethal toxin for targeted delivery
|
|
WO2014035364A2
(en)
*
|
2012-08-27 |
2014-03-06 |
Empire Technology Development Llc |
Gelatin alkyd peptides and uses thereof
|
|
EP2890402B1
(en)
|
2012-08-31 |
2019-04-17 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
|
EP2898085B1
(en)
|
2012-09-24 |
2019-01-23 |
MedImmune Limited |
Cell lines
|
|
EP3395358B1
(en)
|
2012-09-26 |
2019-11-06 |
Indiana University Research and Technology Corporation |
Insulin analog dimers
|
|
CN102875733B
(zh)
*
|
2012-10-25 |
2014-06-11 |
西安科技大学 |
具有仿细胞外层膜结构的纳米颗粒及其制备方法
|
|
US20140120116A1
(en)
|
2012-10-26 |
2014-05-01 |
The Chinese University Of Hong Kong |
Treatment of cancer using smad3 inhibitor
|
|
UY35144A
(es)
|
2012-11-20 |
2014-06-30 |
Novartis Ag |
Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
|
|
PL2935320T3
(pl)
|
2012-12-18 |
2020-03-31 |
Novartis Ag |
Stabilizowane polipeptydy insulinopodobnego czynnika wzrostu
|
|
CA2936092A1
(en)
|
2013-01-23 |
2014-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stabilized hepatitis b core polypeptide
|
|
WO2014131024A2
(en)
|
2013-02-25 |
2014-08-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
US9255255B2
(en)
|
2013-03-04 |
2016-02-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Synthesis of linear and branched polymers of polypeptides through direct conjugation
|
|
UY35368A
(es)
|
2013-03-08 |
2014-10-31 |
Irm Llc |
Péptidos y composiciones para el tratamiento de daño articular
|
|
JP6538645B2
(ja)
|
2013-03-14 |
2019-07-03 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ |
インスリン‐インクレチン複合物
|
|
WO2014145654A1
(en)
|
2013-03-15 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Method for the site-specific covalent cross-linking of antibodies to surfaces
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
WO2014145718A2
(en)
|
2013-03-15 |
2014-09-18 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
JP6574754B2
(ja)
|
2013-03-19 |
2019-09-11 |
ベイジン シェノゲン ファーマ グループ リミテッド |
エストロゲン受容体関連疾患を処置するための抗体及び方法
|
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|
|
KR101568336B1
(ko)
|
2013-07-02 |
2015-11-12 |
서강대학교산학협력단 |
목적 단백질의 돌연변이체를 생성하는 세포, 상기 세포의 제조 방법, 및 상기 세포를 이용한 목적 단백질의 돌연변이체의 제조 방법
|
|
WO2015006555A2
(en)
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3021942A4
(en)
|
2013-07-19 |
2017-04-19 |
The Regents of The University of California |
Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
|
|
KR20160031551A
(ko)
|
2013-07-25 |
2016-03-22 |
노파르티스 아게 |
심부전의 치료를 위한 시클릭 폴리펩티드
|
|
HK1218252A1
(zh)
|
2013-07-25 |
2017-02-10 |
Novartis Ag |
合成apelin多肽之生物结合物
|
|
AU2014305843B2
(en)
|
2013-08-09 |
2019-08-29 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
WO2015031268A1
(en)
|
2013-08-26 |
2015-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
High affinity synbodies for influenza
|
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
JP6661531B2
(ja)
|
2013-10-10 |
2020-03-11 |
シナジー ファーマシューティカルズ インコーポレイテッド |
オピオイド誘発性機能障害の治療に有用なグアニル酸シクラーゼのアゴニスト
|
|
EP3055298B1
(en)
|
2013-10-11 |
2020-04-29 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
EP3057605A1
(en)
|
2013-10-18 |
2016-08-24 |
Novartis AG |
Methods of treating diabetes and related disorders
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
EP3094977B1
(en)
|
2014-01-14 |
2018-08-22 |
European Molecular Biology Laboratory |
Multiple cycloaddition reactions for labeling of molecules
|
|
WO2015120287A2
(en)
*
|
2014-02-06 |
2015-08-13 |
Yale University |
Compositions and methods of use thereof for making polypeptides with many instances of nonstandard amino acids
|
|
ES2913205T3
(es)
|
2014-05-13 |
2022-06-01 |
Bioatla Inc |
Proteínas biológicas activas condicionalmente
|
|
SG11201609706VA
(en)
|
2014-06-23 |
2017-01-27 |
Novartis Ag |
Site specific protein modifications
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
US10316322B2
(en)
|
2014-07-02 |
2019-06-11 |
Sutro Biopharma, Inc. |
High growth capacity auxotrophic Escherichia coli and methods of use
|
|
CA2954791C
(en)
|
2014-07-14 |
2025-11-18 |
The Regents Of The University Of California |
CRISPR/CAS TRANSCRIPTIONAL MODULATION
|
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
|
WO2016036916A1
(en)
|
2014-09-03 |
2016-03-10 |
Bioatla, Llc |
Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts
|
|
CN108271356A
(zh)
|
2014-09-24 |
2018-07-10 |
印第安纳大学研究及科技有限公司 |
肠降血糖素-胰岛素缀合物
|
|
JP6701208B2
(ja)
|
2014-09-24 |
2020-05-27 |
インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション |
脂質化アミド系インスリンプロドラッグ
|
|
US11408007B2
(en)
|
2014-09-26 |
2022-08-09 |
Yale University |
Compositions and methods for biocontainment of microorganisms
|
|
CN114805532A
(zh)
|
2014-10-24 |
2022-07-29 |
百时美施贵宝公司 |
修饰的fgf-21多肽及其用途
|
|
US10335495B2
(en)
|
2014-12-04 |
2019-07-02 |
Celgene Corporation |
Biomolecule conjugates
|
|
WO2016106286A1
(en)
|
2014-12-23 |
2016-06-30 |
Biodesy, Inc. |
Attachment of proteins to interfaces for use in nonlinear optical detection
|
|
SE538541C2
(en)
*
|
2015-01-19 |
2016-09-13 |
Fogelstrand Per |
Method for preparing a biological sample for use in an immunolabeling process
|
|
CN107209176B
(zh)
|
2015-01-21 |
2020-08-14 |
克罗姆尼贡公司 |
免疫标记复合物的形成方法及用途
|
|
MA41580A
(fr)
|
2015-01-23 |
2017-11-29 |
Novartis Ag |
Conjugués d'acides gras de l'apeline synthétique présentant une demi-vie améliorée
|
|
WO2016123578A1
(en)
|
2015-01-30 |
2016-08-04 |
The Regents Of The University Of California |
Protein delivery in primary hematopoietic cells
|
|
EP4166664A1
(en)
|
2015-03-13 |
2023-04-19 |
Chugai Seiyaku Kabushiki Kaisha |
Modified aminoacyl-trna synthetase and use thereof
|
|
US10483262B2
(en)
*
|
2015-05-15 |
2019-11-19 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Dual nitride stressor for semiconductor device and method of manufacturing
|
|
WO2016199801A1
(ja)
*
|
2015-06-09 |
2016-12-15 |
国立研究開発法人産業技術総合研究所 |
アミノ酸修飾核酸とその利用
|
|
EP3307326B9
(en)
|
2015-06-15 |
2021-02-24 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
EP3331551B1
(en)
|
2015-07-10 |
2021-06-23 |
The Hong Kong University of Science and Technology |
Compositions for use in treating neurodegenerative and neuroinflammatory conditions
|
|
WO2017062334A1
(en)
|
2015-10-05 |
2017-04-13 |
Merck Sharp & Dohme Corp. |
Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
|
|
IL310721B2
(en)
|
2015-10-23 |
2025-11-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
JP6946304B2
(ja)
|
2015-12-22 |
2021-10-06 |
ノバルティス アーゲー |
増殖分化因子１５（ｇｄｆ−１５）を使用して代謝障害を処置するまたは軽快させる方法
|
|
UA127495C2
(uk)
|
2015-12-23 |
2023-09-13 |
Амджен Інк. |
Виділений антигензв'язуючий білок, який специфічно зв'язується з поліпептидом рецептора шлункового інгібіторного пептиду (gipr) людини, та фармацевтична композиція, яка його містить
|
|
CN106929482A
(zh)
*
|
2015-12-31 |
2017-07-07 |
北京大学 |
定点突变的流感病毒、其活疫苗及其制备方法和应用
|
|
US10653744B2
(en)
|
2016-01-11 |
2020-05-19 |
Bausch Health Ireland Limited |
Formulations and methods for treating ulcerative colitis
|
|
WO2017132615A1
(en)
|
2016-01-27 |
2017-08-03 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール．ピー．シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
|
EP3455628A4
(en)
|
2016-05-09 |
2019-12-04 |
Biodesy, Inc. |
METHOD AND DEVICES FOR DETECTING INTERACTIONS OF PERIPHERAL MEMBRANE PROTEINS USING NONLINEAR OPTICAL TECHNIQUES
|
|
WO2017204729A1
(en)
*
|
2016-05-25 |
2017-11-30 |
Fogelstrand Per |
Method for preparing a biological sample for use in an immunolabeling process
|
|
AU2017283787B2
(en)
|
2016-06-15 |
2020-09-17 |
Novartis Ag |
Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)
|
|
CN110214183A
(zh)
|
2016-08-03 |
2019-09-06 |
哈佛大学的校长及成员们 |
腺苷核碱基编辑器及其用途
|
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
EP3309260A1
(en)
|
2016-10-14 |
2018-04-18 |
European Molecular Biology Laboratory |
Archaeal pyrrolysyl trna synthetases for orthogonal use
|
|
KR102622411B1
(ko)
|
2016-10-14 |
2024-01-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
JP2020500020A
(ja)
|
2016-11-14 |
2020-01-09 |
ノバルティス アーゲー |
融合誘導性タンパク質ｍｉｎｉｏｎに関連する組成物、方法、および治療上の使用
|
|
KR20240045351A
(ko)
|
2016-11-14 |
2024-04-05 |
노파르티스 아게 |
연골 손상 및 관절염 치료 방법 및 조성물
|
|
WO2018118997A2
(en)
|
2016-12-19 |
2018-06-28 |
Quantum-Si Incorporated |
Polymerizing enzymes for sequencing reactions
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
CN110366428B
(zh)
|
2016-12-30 |
2024-05-17 |
Vaxcyte公司 |
具有非天然氨基酸的多肽-抗原缀合物
|
|
IL313587A
(en)
|
2017-01-17 |
2024-08-01 |
Amgen Inc |
Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)
|
|
JP7187323B2
(ja)
|
2017-01-31 |
2022-12-12 |
中外製薬株式会社 |
無細胞翻訳系におけるペプチドの合成方法
|
|
US11730828B2
(en)
|
2017-02-07 |
2023-08-22 |
The Regents Of The University Of California |
Gene therapy for haploinsufficiency
|
|
PE20191716A1
(es)
|
2017-02-08 |
2019-12-05 |
Bristol Myers Squibb Co |
Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos
|
|
US12390514B2
(en)
|
2017-03-09 |
2025-08-19 |
President And Fellows Of Harvard College |
Cancer vaccine
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
US11542496B2
(en)
|
2017-03-10 |
2023-01-03 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
KR20240116572A
(ko)
|
2017-03-23 |
2024-07-29 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
|
EP3381932A1
(en)
|
2017-03-28 |
2018-10-03 |
Technische Universität Berlin |
Modified mussel proteins, uses thereof and related compounds
|
|
CA3060514A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
PL3630977T3
(pl)
|
2017-06-02 |
2024-06-24 |
Ambrx, Inc. |
Sposoby i kompozycje promujące produkcję białek zawierających nienaturalne aminokwasy
|
|
KR20250007021A
(ko)
|
2017-06-09 |
2025-01-13 |
추가이 세이야쿠 가부시키가이샤 |
N-치환 아미노산을 포함하는 펩타이드의 합성 방법
|
|
EA201992502A1
(ru)
|
2017-06-20 |
2020-04-22 |
Эмджен Инк. |
Способ лечения или уменьшения интенсивности метаболических нарушений с применением белков, связывающих рецептор гастроингибиторного пептида (gipr), в комбинации с агонистами glp-1
|
|
EP3642238A1
(en)
|
2017-06-21 |
2020-04-29 |
Amgen Inc. |
Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (gipr)/glp-1 receptor agonist fusion proteins
|
|
JP7325341B2
(ja)
*
|
2017-07-11 |
2023-08-14 |
シンソークス，インク． |
非天然ヌクレオチドの組み込み及びその方法
|
|
KR101956042B1
(ko)
*
|
2017-07-13 |
2019-03-08 |
서강대학교산학협력단 |
표적 단백질 내 l-디하이드록시페닐알라닌의 도입 방법
|
|
WO2019023316A1
(en)
|
2017-07-26 |
2019-01-31 |
Sutro Biopharma, Inc. |
METHODS OF USING ANTI-CD74 ANTIBODIES AND ANTIBODY CONJUGATES IN THE TREATMENT OF A T CELL LYMPHOMA
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
KR20240141853A
(ko)
|
2017-08-03 |
2024-09-27 |
신톡스, 인크. |
자가면역 질환의 치료를 위한 사이토카인 접합체
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
JP2020534352A
(ja)
|
2017-09-07 |
2020-11-26 |
キュー バイオファーマ，インコーポレーテッド |
コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法
|
|
KR20250035037A
(ko)
|
2017-09-18 |
2025-03-11 |
서트로 바이오파마, 인크. |
항-엽산 수용체 알파 항체 접합체 및 이의 용도
|
|
KR20250107288A
(ko)
|
2017-10-16 |
2025-07-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
WO2019117274A1
(ja)
|
2017-12-15 |
2019-06-20 |
中外製薬株式会社 |
ペプチドの製造方法、及び塩基の処理方法
|
|
US12404512B2
(en)
|
2018-05-01 |
2025-09-02 |
Ambrx, Inc. |
Method for optimizing antibody expression
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
WO2019237119A1
(en)
|
2018-06-08 |
2019-12-12 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and detection methods for onchocerca volvulus infection
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
CN112673109A
(zh)
*
|
2018-09-07 |
2021-04-16 |
免疫医疗有限责任公司 |
细胞选择方法
|
|
CA3111576A1
(en)
|
2018-09-11 |
2020-03-19 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
|
JP2022500454A
(ja)
|
2018-09-17 |
2022-01-04 |
ストロ バイオファーマ インコーポレーテッド |
抗葉酸受容体抗体コンジュゲートによる併用療法
|
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス，インコーポレイテッド |
インターロイキン－１０ポリペプチド複合体、その二量体、およびそれらの使用
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
US11325978B2
(en)
|
2018-11-06 |
2022-05-10 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Compositions and methods for treating beta-globinopathies
|
|
EP3878836B1
(en)
|
2018-11-07 |
2025-07-23 |
Chugai Seiyaku Kabushiki Kaisha |
O-substituted serine derivative production method
|
|
WO2020111238A1
(ja)
|
2018-11-30 |
2020-06-04 |
中外製薬株式会社 |
ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
EP3923974A4
(en)
|
2019-02-06 |
2023-02-08 |
Synthorx, Inc. |
IL-2 CONJUGATES AND METHODS OF USE THEREOF
|
|
CA3128081A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
|
EP3696189A1
(en)
|
2019-02-14 |
2020-08-19 |
European Molecular Biology Laboratory |
Means and methods for preparing engineered target proteins by genetic code expansion in a target protein selective manner
|
|
JP7495420B2
(ja)
|
2019-02-20 |
2024-06-04 |
ノヴォ ノルディスク アー／エス |
アミノアシル－ｔＲＮＡ合成酵素およびこの使用
|
|
US12371817B2
(en)
|
2019-03-04 |
2025-07-29 |
The Texas A&M University System |
Methods of making and utilizing amber-obligated phage display libraries
|
|
EP3939962A4
(en)
|
2019-03-15 |
2022-12-28 |
Chugai Seiyaku Kabushiki Kaisha |
PROCESS FOR PREPARING AN AROMATIC AMINO ACID DERIVATIVE
|
|
WO2020191233A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
WO2020227105A1
(en)
|
2019-05-03 |
2020-11-12 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
|
US12258304B2
(en)
|
2019-05-20 |
2025-03-25 |
Albert Einstein College Of Medicine |
Compounds and methods for treatment of bacterial infections
|
|
EP3980057A1
(en)
|
2019-06-04 |
2022-04-13 |
Institut Curie |
Methods of producing shiga toxin b-subunit (stxb) monomers and oligomers, and uses thereof
|
|
US12139708B2
(en)
|
2019-06-07 |
2024-11-12 |
Massachusetts Institute Of Technology |
Frameshift suppressor tRNA compositions and methods of use
|
|
JP7706210B2
(ja)
|
2019-06-10 |
2025-07-11 |
ストロ バイオファーマ インコーポレーテッド |
５Ｈ－ピロロ［３，２－ｄ］ピリミジン－２，４－ジアミノ化合物およびその抗体コンジュゲート
|
|
CN114746420A
(zh)
|
2019-06-17 |
2022-07-12 |
苏特罗生物制药公司 |
用于癌症治疗和诊断的作为Toll样受体（TLR）7/8激动剂的1-(4-(氨基甲基)苄基)-2-丁基-2H-吡唑并[3,4-c]喹啉-4-胺衍生物及相关化合物以及其抗体药物偶联物
|
|
US11959105B2
(en)
|
2019-06-28 |
2024-04-16 |
Quantum-Si Incorporated |
Polymerizing enzymes for sequencing reactions
|
|
KR20220076510A
(ko)
|
2019-10-08 |
2022-06-08 |
트러스티스 오브 보스톤 칼리지 |
다수의 서로 다른 비천연 아미노산을 함유하는 단백질 및 이러한 단백질의 제조 및 사용 방법
|
|
TW202128996A
(zh)
*
|
2019-10-10 |
2021-08-01 |
美商史基普研究協會 |
用於活體內合成非天然多肽的組合物及方法
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
US20230279378A1
(en)
*
|
2019-10-15 |
2023-09-07 |
Trustees Of Boston College |
Chimeric thermostable aminoacyl-trna synthetase for enhanced unnatural amino acid incorporation
|
|
US11149280B2
(en)
|
2019-10-29 |
2021-10-19 |
Yale University |
Engineering organisms resistant to viruses and horizontally transferred genetic elements
|
|
CA3157470A1
(en)
*
|
2019-11-05 |
2021-05-14 |
Neil Butler |
Biosynthesis of para-nitro-l-phenylalanine
|
|
BR112022007535A2
(pt)
|
2019-11-07 |
2022-07-12 |
Chugai Pharmaceutical Co Ltd |
Composto peptídico cíclico tendo ação inibitória de kras
|
|
EP4085077A4
(en)
|
2019-12-31 |
2024-01-17 |
Beijing QL Biopharmaceutical Co., Ltd. |
Fusion proteins of glp-1 and gdf15 and conjugates thereof
|
|
JP7813706B2
(ja)
|
2020-01-03 |
2026-02-13 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
歯周の健康を促進するために局所投与されるｔｎａｐ
|
|
CN113728013B
(zh)
|
2020-01-11 |
2022-06-14 |
北京质肽生物医药科技有限公司 |
Glp-1和fgf21的融合蛋白的缀合物
|
|
EP4107258A4
(en)
*
|
2020-02-20 |
2024-04-17 |
B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University |
MUTANT AMINOACYL-ARNT SYNTHETASES
|
|
EP3868882A1
(en)
|
2020-02-21 |
2021-08-25 |
European Molecular Biology Laboratory |
Archaeal pyrrolysyl trna synthetases for orthogonal use
|
|
US20230095053A1
(en)
|
2020-03-03 |
2023-03-30 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
|
|
EP4117732A1
(en)
|
2020-03-11 |
2023-01-18 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
|
CN111302975A
(zh)
*
|
2020-03-30 |
2020-06-19 |
滨海吉尔多肽有限公司 |
一种n-叔丁氧羰基-o-烯丙基-l-酪氨酸的制备方法
|
|
PE20231648A1
(es)
|
2020-04-22 |
2023-10-17 |
Merck Sharp And Dohme Llc |
CONJUGADOS DE INTERLEUCINA 2 HUMANA SESGADOS AL DIMERO DEL RECEPTOR DE INTERLEUCINA 2 byc Y CONJUGADOS CON UN POLIMERO HIDROSOLUBLE NO PEPTIDICO
|
|
US12351850B2
(en)
|
2020-04-30 |
2025-07-08 |
Sutro Biopharma, Inc. |
Methods of producing full-length antibodies using E. coli
|
|
AR122020A1
(es)
|
2020-05-05 |
2022-08-03 |
Genentech Inc |
Sistemas y métodos para la conjugación específica de sitio de proteínas mediada por tirosinasa
|
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
|
CN115835904A
(zh)
|
2020-05-22 |
2023-03-21 |
武田药品工业有限公司 |
用于治疗和诊断冠状病毒疾病并发症的adamts13组合物和方法
|
|
JP2023538071A
(ja)
|
2020-08-20 |
2023-09-06 |
アンブルックス，インコーポレイテッド |
抗体－ｔｌｒアゴニストコンジュゲート、その方法及び使用
|
|
US20220089690A1
(en)
*
|
2020-09-14 |
2022-03-24 |
Sutro Biopharma, Inc. |
Method for large scale production of antibodies using a cell-free protein synthesis system
|
|
CN114729060B
(zh)
|
2020-09-30 |
2022-11-25 |
北京质肽生物医药科技有限公司 |
多肽缀合物和使用方法
|
|
CA3213805A1
(en)
|
2021-04-03 |
2022-10-06 |
Feng Tian |
Anti-her2 antibody-drug conjugates and uses thereof
|
|
US20230016731A1
(en)
*
|
2021-05-21 |
2023-01-19 |
The Regents Of The University Of California |
Affinity purification sequencing
|
|
AU2022306974A1
(en)
|
2021-07-09 |
2024-01-04 |
Bright Peak Therapeutics Ag |
Modified il-2 polypeptides for treatment of inflammatory and autoimmune diseases
|
|
EP4366781A1
(en)
|
2021-07-09 |
2024-05-15 |
Bright Peak Therapeutics AG |
Checkpoint inhibitors conjugated to il-2, and uses thereof
|
|
US20230201365A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Modified cd20 antibodies and uses thereof
|
|
US20230201364A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Antibody conjugates and manufacture thereof
|
|
WO2023281480A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Conjugates of checkpoint inhibitors with il-2, and uses thereof
|
|
US12606598B2
(en)
|
2021-07-12 |
2026-04-21 |
Bactoclear Holdings PTE, Ltd. |
Chimeric klebicins
|
|
US20250327057A1
(en)
|
2021-09-06 |
2025-10-23 |
Veraxa Biotech Gmbh |
Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
|
|
JP2024533596A
(ja)
*
|
2021-09-17 |
2024-09-12 |
アブサイ コーポレイション |
トランスファーｒｎａの組成、及び非標準アミノ酸を含むタンパク質の生産における使用
|
|
US20240384267A1
(en)
|
2021-09-20 |
2024-11-21 |
The Broad Institute, Inc. |
Compositions and methods for multiplex decoding of quadruplet codons
|
|
CA3234552A1
(en)
|
2021-10-20 |
2023-04-27 |
Synthekine, Inc. |
Heterodimeric fc cytokines and uses thereof
|
|
WO2023081167A2
(en)
|
2021-11-02 |
2023-05-11 |
The Regents Of The University Of California |
P-selectin mutants and modulation of integrin-mediated signaling
|
|
WO2023094525A1
(en)
|
2021-11-25 |
2023-06-01 |
Veraxa Biotech Gmbh |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
|
DK4186529T3
(da)
|
2021-11-25 |
2025-08-25 |
Veraxa Biotech Gmbh |
Forbedrede antistof-payload-konjugater (apc) fremstillet ved stedspecifik konjugering ved hjælp af genetisk kodeudvidelse
|
|
US20250135011A1
(en)
|
2021-12-08 |
2025-05-01 |
European Molecular Biology Laboratory |
Hydrophilic tetrazine-functionalized payloads for preparation of targeting conjugates
|
|
US20250092106A1
(en)
|
2022-01-25 |
2025-03-20 |
The Regents Of The University Of California |
Vegf mutants and modulation of integrin-mediated signaling
|
|
AU2023226512A1
(en)
|
2022-02-23 |
2024-08-29 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
|
WO2023161857A1
(en)
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Bifunctional cytokine compositions
|
|
EP4323413A4
(en)
|
2022-03-30 |
2025-10-15 |
Beijing Ql Biopharmaceutical Co Ltd |
LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF
|
|
CA3259758A1
(en)
|
2022-06-30 |
2024-01-04 |
Sutro Biopharma, Inc. |
Anti-ROR1 antibodies and antibody conjugates, compositions comprising anti-ROR1 antibodies or antibody conjugates, and methods of manufacturing and using anti-ROR1 antibodies and antibody conjugates
|
|
CN116376851A
(zh)
*
|
2022-08-25 |
2023-07-04 |
凯莱英医药集团（天津）股份有限公司 |
氨酰tRNA合酶突变体及其应用
|
|
NL2033185B1
(en)
|
2022-09-29 |
2024-04-08 |
Stichting Vu |
Compounds for rna stabilisation and delivery
|
|
WO2024077277A1
(en)
|
2022-10-07 |
2024-04-11 |
Ambrx, Inc. |
Drug linkers and antibody conjugates thereof
|
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
|
WO2024141087A1
(zh)
*
|
2022-12-31 |
2024-07-04 |
康码（上海）生物科技有限公司 |
一种用于插入非天然氨基酸的体外无细胞蛋白质合成体系、方法及应用
|
|
US20240376170A1
(en)
|
2023-01-11 |
2024-11-14 |
Bright Peak Therapeutics Ag |
Conditionally activated proteins and methods of use
|
|
JP2026504093A
(ja)
|
2023-01-16 |
2026-02-03 |
アンブレツクス・インコーポレイテツド |
抗ｃｄ７０抗体薬物コンジュゲート
|
|
WO2024178310A1
(en)
|
2023-02-23 |
2024-08-29 |
Ambrx, Inc. |
Trop2-directed antibody-drug conjugates and uses thereof
|
|
EP4689127A1
(en)
|
2023-04-03 |
2026-02-11 |
Sutro Biopharma, Inc. |
Rf1 ko e. coli strains
|
|
WO2024241086A1
(en)
|
2023-05-24 |
2024-11-28 |
Ambrx, Inc. |
Pegylated bovine interferon lambda and methods of use thereof
|
|
KR20260046464A
(ko)
|
2023-07-27 |
2026-04-07 |
베락사 바이오테크 게엠베하 |
친수성 트랜스-시클로옥텐(hyTCO) 화합물, 이를 포함하는 구조체 및 접합체
|
|
AU2024329469A1
(en)
|
2023-08-22 |
2026-04-09 |
Ambrx, Inc. |
Anti-psma adc conjugate compositions and methods of use thereof
|
|
WO2025041102A1
(en)
|
2023-08-23 |
2025-02-27 |
Bright Peak Therapeutics Ag |
Targeted immune activation with il-18 immunocytokines
|
|
WO2025041101A1
(en)
|
2023-08-23 |
2025-02-27 |
Bright Peak Therapeutics Ag |
Activatable il-18 immunocytokines and uses thereof
|
|
AU2024358957A1
(en)
|
2023-10-13 |
2026-04-02 |
Sutro Biopharma, Inc. |
Anti-tissue factor antibodies and antibody conjugates, compositions comprising anti-tissue factor antibodies or antibody conjugates, and methods of making and using anti-tissue factor antibodies and antibody conjugates
|
|
WO2025080711A1
(en)
|
2023-10-13 |
2025-04-17 |
Sutro Biopharma, Inc. |
Dual payload antibody drug conjugates
|
|
WO2025176699A1
(en)
|
2024-02-20 |
2025-08-28 |
LenioBio GmbH |
A system and method for cell-free unnatural amino acid incorporation
|
|
WO2025184315A1
(en)
|
2024-02-29 |
2025-09-04 |
Amgen Inc. |
Glucagon receptor agonists, conjugated to glucose-dependent insulinotropic polypeptide antibodies
|
|
WO2025199030A1
(en)
|
2024-03-18 |
2025-09-25 |
Amgen Inc. |
Glp-1 receptor agonists and their medical use
|
|
EP4644408A1
(en)
|
2024-04-19 |
2025-11-05 |
The Chinese University of Hong Kong Office of Research and Knowledge Transfer Services (ORKTS) |
Polyethylenimine-modified cry proteins and their use
|
|
WO2025257694A1
(en)
|
2024-06-10 |
2025-12-18 |
Università Degli Studi Di Torino |
Cell differentiation through multimodal tuning of gene expression
|
|
WO2025257695A1
(en)
|
2024-06-10 |
2025-12-18 |
Università Degli Studi Di Torino |
Growth factor-free stem cell expansion and differentiation
|
|
WO2026043823A2
(en)
|
2024-08-19 |
2026-02-26 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of preparation and uses thereof
|
|
WO2026069134A1
(en)
|
2024-09-26 |
2026-04-02 |
Bright Peak Therapeutics Ag |
Human therapy with il-18 immunocytokines
|
|
WO2026080688A1
(en)
|
2024-10-09 |
2026-04-16 |
Sutro Biopharma, Inc. |
Dual mechanism of action payload antibody drug conjugates
|
|
WO2026080697A1
(en)
|
2024-10-09 |
2026-04-16 |
Sutro Biopharma, Inc. |
Antibody conjugates with high payload to antibody ratios, compositions comprising the same, and methods of their use
|
|
WO2026083295A1
(en)
|
2024-10-16 |
2026-04-23 |
Bright Peak Therapeutics Ag |
Trispecific compositions comprising il-2, vegf binding domains, and pd-1 binding domains
|
|
WO2026083296A1
(en)
|
2024-10-16 |
2026-04-23 |
Bright Peak Therapeutics Ag |
Trispecific compositions comprising il-18, vegf binding domains, and pd-1 binding domains
|